Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924 |
Resumo: | Introduction: Adverse drug reactions (ADR’s) are considered a serious public health problem, being responsible for the increase in morbidity and mortality and health costs. Objective: To know the occurrence profile and describe the characteristics of the cases of ADRs notified in a sentinel hospital in Minas Gerais. Method: Observational, descriptive and cross-sectional study, which used as a source the spreadsheet of suspected ADR’s reports from the hospital's risk management from January 2015 to December 2019. Results: 255 notifications were analyzed, the majority coming from active search (69.4%), involving 269 medications and 328 episodes of ADR’s. The sector with the highest number of notifications was the Medical Clinic (43.9%). The age range of the most affected patients was between 19-59 years (54.5%), predominantly male (50.6%) and white (54.1%). Most of the ADR's were manifested through disorders in the integumentary system (36.3%), with mild severity (63.9%), mainly due to the use of systemic anti-infectives (44.6%). Conclusion: It is concluded that the notifications of ADR’s are recurrent in the hospital and their knowledge allows to outline their clinical profile, helping to prevent them and contributing to greater patient safety. |
id |
FIOCRUZ-9_e1e4a4fec5f4a8a1ee67c664e149d83f |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1924 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Evaluation of adverse drug reactions notifications at a public hospital in Minas GeraisAvaliação das notificações de reações adversas a medicamentos em um hospital público de Minas GeraisPharmacovigilance; Notifcation; Adverse Drug ReactionsFarmacovigilância; Notifcação; Reações Adversas a MedicamentosIntroduction: Adverse drug reactions (ADR’s) are considered a serious public health problem, being responsible for the increase in morbidity and mortality and health costs. Objective: To know the occurrence profile and describe the characteristics of the cases of ADRs notified in a sentinel hospital in Minas Gerais. Method: Observational, descriptive and cross-sectional study, which used as a source the spreadsheet of suspected ADR’s reports from the hospital's risk management from January 2015 to December 2019. Results: 255 notifications were analyzed, the majority coming from active search (69.4%), involving 269 medications and 328 episodes of ADR’s. The sector with the highest number of notifications was the Medical Clinic (43.9%). The age range of the most affected patients was between 19-59 years (54.5%), predominantly male (50.6%) and white (54.1%). Most of the ADR's were manifested through disorders in the integumentary system (36.3%), with mild severity (63.9%), mainly due to the use of systemic anti-infectives (44.6%). Conclusion: It is concluded that the notifications of ADR’s are recurrent in the hospital and their knowledge allows to outline their clinical profile, helping to prevent them and contributing to greater patient safety. Introdução: As reações adversas a medicamentos (RAM’s) são consideradas um grave problema de saúde pública, sendo responsáveis pelo aumento da morbimortalidade e dos custos com a saúde. Objetivo: Conhecer o perfil de ocorrência e descrever as características dos casos de RAM’s notificadas em um hospital sentinela de Minas Gerais. Método: Estudo observacional, descritivo e transversal, que utilizou como fonte a planilha de notificações de suspeita de RAM’s da gerência de risco do hospital no período de janeiro de 2015 a dezembro de 2019. Resultados: Foram analisadas 255 notificações, sendo a maioria provenientes de busca ativa (69,4%), envolvendo 269 medicamentos e 328 episódios de RAM’s. O setor com maior número de notificações foi a Clínica Médica (43,9%). A faixa etária dos pacientes mais acometidos situou-se entre 19-59 anos (54,5%), predominando o sexo masculino (50,6%) e a raça branca (54,1%). Grande parte das RAM’s manifestou-se através de distúrbios no sistema tegumentar (36,3%), com gravidade leve (63,9%), provindas principalmente do uso de anti-infecciosos sistêmicos (44,6%). Conclusão: Conclui-se que as notificações de RAM’s são recorrentes no âmbito hospitalar e o conhecimento destas permite traçar seu perfil clínico, auxiliando na prevenção das mesmas e contribuindo para maior segurança do paciente.Instituto Nacional de Controle de Qualidade em Saúde2021-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/192410.22239/2317-269X.01924Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 4 (2021): November; 57-65Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 4 (2021): Noviembre; 57-65Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 4 (2021): Novembro; 57-652317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924/1380https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924/1427Copyright (c) 2021 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologiahttps://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessde Lima, Thaís CristinaPortes de Almeida, Priscila Gontijo de Oliveira Rezende, Dayana 2023-06-27T15:13:49Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1924Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:13:49Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais Avaliação das notificações de reações adversas a medicamentos em um hospital público de Minas Gerais |
title |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
spellingShingle |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais de Lima, Thaís Cristina Pharmacovigilance; Notifcation; Adverse Drug Reactions Farmacovigilância; Notifcação; Reações Adversas a Medicamentos |
title_short |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
title_full |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
title_fullStr |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
title_full_unstemmed |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
title_sort |
Evaluation of adverse drug reactions notifications at a public hospital in Minas Gerais |
author |
de Lima, Thaís Cristina |
author_facet |
de Lima, Thaís Cristina Portes de Almeida, Priscila Gontijo de Oliveira Rezende, Dayana |
author_role |
author |
author2 |
Portes de Almeida, Priscila Gontijo de Oliveira Rezende, Dayana |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
de Lima, Thaís Cristina Portes de Almeida, Priscila Gontijo de Oliveira Rezende, Dayana |
dc.subject.por.fl_str_mv |
Pharmacovigilance; Notifcation; Adverse Drug Reactions Farmacovigilância; Notifcação; Reações Adversas a Medicamentos |
topic |
Pharmacovigilance; Notifcation; Adverse Drug Reactions Farmacovigilância; Notifcação; Reações Adversas a Medicamentos |
description |
Introduction: Adverse drug reactions (ADR’s) are considered a serious public health problem, being responsible for the increase in morbidity and mortality and health costs. Objective: To know the occurrence profile and describe the characteristics of the cases of ADRs notified in a sentinel hospital in Minas Gerais. Method: Observational, descriptive and cross-sectional study, which used as a source the spreadsheet of suspected ADR’s reports from the hospital's risk management from January 2015 to December 2019. Results: 255 notifications were analyzed, the majority coming from active search (69.4%), involving 269 medications and 328 episodes of ADR’s. The sector with the highest number of notifications was the Medical Clinic (43.9%). The age range of the most affected patients was between 19-59 years (54.5%), predominantly male (50.6%) and white (54.1%). Most of the ADR's were manifested through disorders in the integumentary system (36.3%), with mild severity (63.9%), mainly due to the use of systemic anti-infectives (44.6%). Conclusion: It is concluded that the notifications of ADR’s are recurrent in the hospital and their knowledge allows to outline their clinical profile, helping to prevent them and contributing to greater patient safety. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924 10.22239/2317-269X.01924 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924 |
identifier_str_mv |
10.22239/2317-269X.01924 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924/1380 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1924/1427 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia https://creativecommons.org/licenses/by-nc/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia https://creativecommons.org/licenses/by-nc/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 4 (2021): November; 57-65 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 4 (2021): Noviembre; 57-65 Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 4 (2021): Novembro; 57-65 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042046562729984 |